CO-DIAGNOSTICS, INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$264K
↑+76.7% +$115Kvs FY2024 (Q4)
Gross Profit
$122K
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $264K | $149K |
| COGS | $142K | $149K |
| Gross Profit | $122K | $0 |
| R&D | $5M | $5M |
| SG&A | $0 | $0 |
| D&A | $268K | $357K |
| Other OpEx | $0 | $0 |
| Operating Income | $0 | $0 |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · CODX · Comparing FY2025 (Q4) vs FY2024 (Q4)